Accession Number:

AD1094753

Title:

Novel Therapeutic Target Identification through Analysis of Convergent AD and TBI Pathogenic Mechanisms

Descriptive Note:

Technical Report,15 Sep 2017,14 Sep 2018

Corporate Author:

The Roskamp Institute Sarasota United States

Personal Author(s):

Report Date:

2018-10-01

Pagination or Media Count:

22.0

Abstract:

We plan to identify and provide preliminary validation for novel targets for the TBI-AD interrelationship discovered through our molecular level profiling. The goal here is to target validation and provision of these therapeutic targets for future studies in drug discovery and preclinical efficacy i.e. IND enabling studies of new therapeutic approaches to the AD sequelae of TBI.

Subject Categories:

  • Medicine and Medical Research
  • Magnetic and Electric Field Detection and Detectors

Distribution Statement:

APPROVED FOR PUBLIC RELEASE